Analysis of Tau Protein Expression in Predicting Pathological Complete Response to Neoadjuvant Chemotherapy in Different Molecular Subtypes of Breast Cancer

Journal of breast cancer
Chuqian LeiKun Wang

Abstract

Tau is a microtubule-associated protein that can be found in both normal and abnormal breast cells. Whether the expression of Tau protein can predict the response to neoadjuvant chemotherapy (NACT) is still unclear. In this study, we assessed the role of Tau protein expression in predicting a pathological complete response (pCR) to NACT for different subtypes of breast cancer. Four hundred and sixty-eight eligible patients were retrospectively recruited in our study. The relationship between clinicopathologic factors, including Tau protein expression, and pCR in different subtypes was evaluated using logistic regression analysis. Correlation between Tau and disease-free survival (DFS) and overall survival (OS) was performed using Kaplan-Meier analysis. The expression of Tau protein was negatively correlated with pCR, especially in triple-negative breast cancer (TNBC). No significant difference was observed in the luminal human epidermal growth factor receptor-2 (HER2)-negative subtype and HER2-positive subtype. Patients with pCR were associated with better DFS and OS (p < 0.05). However, Tau protein expression had no association with either DFS or OS (p > 0.05). Tau protein expression can predict pCR before NACT in TNBC, but th...Continue Reading

References

May 26, 2005·Proceedings of the National Academy of Sciences of the United States of America·Roman RouzierLajos Pusztai
Aug 10, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kenneth R HessLajos Pusztai
Apr 4, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fabrice AndreLajos Pusztai
Jul 3, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chafika MazouniLajos Pusztai
Jul 20, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Florentia PeintingerLajos Pusztai
Sep 6, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·W Fraser SymmansLajos Pusztai
Nov 14, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M KaufmannS Loibl
Feb 6, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cornelia LiedtkeLajos Pusztai
Aug 12, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lajos PusztaiW Fraser Symmans
Jun 26, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Charles DumontetJohn C Reed
Apr 18, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gunter von MinckwitzSibylle Loibl
Sep 15, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Kun WangYi-Long Wu
Jun 19, 2013·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Mai KawaseHiroko Yamashita
Jul 2, 2017·The Breast : Official Journal of the European Society of Mastology·Nadia Harbeck, Oleg Gluz
Jan 10, 2018·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Mar 11, 2018·Journal of the National Comprehensive Cancer Network : JNCCN·William J GradisharDorothy A Shead
Mar 8, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zhenyu LiuJie Tian

❮ Previous
Next ❯

Citations

Nov 2, 2021·Frontiers in Cell and Developmental Biology·Thomas RicoBruno Lefebvre

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

SPSS

Related Concepts

Related Feeds

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.